Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
Conditions
- Gastrointestinal Carcinoid Tumor
- Islet Cell Carcinoma
Interventions
- DRUG: octreotide acetate
- DRUG: vatalanib
- PROCEDURE: anti-cytokine therapy
- PROCEDURE: antiangiogenesis therapy
- PROCEDURE: biological therapy
- PROCEDURE: endocrine therapy
- PROCEDURE: enzyme inhibitor therapy
- PROCEDURE: growth factor antagonist therapy
- PROCEDURE: hormone therapy
- PROCEDURE: protein tyrosine kinase inhibitor therapy
- PROCEDURE: somatostatin analogue therapy
Sponsor
Eastern Cooperative Oncology Group
Collaborators